cancer care platform
Tampa General Hospital Cancer Institute will integrate Reimagine's platform into its clinical pathways to reduce workforce burden and extend cancer care into the home.
The partnership comes three months after Thyme Care raised $97 million in funding, bringing its total raise to $275 million.
The financing is in addition to a $1.8 million NIH grant for a Veris implantable physiological monitor.
The grant will fund research to improve Veris cancer platform for underserved patients.